Nonantibiotic Prophylaxis Noninferior for Recurrent UTI
Incidence of antibiotic-treated UTI during 12-month treatment period noninferior for methenamine hippurate versus prophylactic antibiotics.
Stay updated with breaking news from Chris Harding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Incidence of antibiotic-treated UTI during 12-month treatment period noninferior for methenamine hippurate versus prophylactic antibiotics.
A new clinical trial finds an old antibiotic alternative might work just as well as an antibiotic to treat UTIs.
A daily dose of an antiseptic drug reduced recurring urinary tract infections as effectively as antibiotics
THURSDAY, March 10, 2022 (HealthDay News) — Nonantibiotic prophylaxis with methenamine hippurate is noninferior to prophylactic antibiotic treatment for women with recurrent urinary tract infection, according to a study published online March 9 in The BMJ. Chris Harding, M.D., from Freeman Hospital in Newcastle upon Tyne, England, and colleagues conducted a multicenter, open-label, noninferiority trial […]
A daily dose of an antiseptic drug reduced recurring urinary tract infections as effectively as antibiotics